2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1019-45-0
|
| gptkbp:commonName |
gptkb:5-MeO-DMT
|
| gptkbp:effect |
mystical experiences
hallucinations altered perception |
| gptkbp:firstSynthesized |
gptkb:Hoshino_and_Shimodaira
|
| gptkbp:foundIn |
gptkb:Bufo_alvarius
gptkb:Anadenanthera_peregrina Virola theiodora |
| gptkbp:hasInChIKey |
GMCMZMGYZCAECN-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C13H18N2O
|
| gptkbp:hasSMILES |
CN(C)CCc1c[nH]c2ccc(OC)cc12
|
| https://www.w3.org/2000/01/rdf-schema#label |
2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
|
| gptkbp:isScheduleIControlledSubstanceIn |
gptkb:United_States
|
| gptkbp:isStructurallyRelatedTo |
gptkb:psilocin
N,N-dimethyltryptamine |
| gptkbp:isTryptamineAlkaloid |
true
|
| gptkbp:IUPACName |
gptkb:2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
|
| gptkbp:molecularWeight |
218.30 g/mol
|
| gptkbp:psychoactive |
true
|
| gptkbp:routeOfAdministration |
oral
inhalation insufflation |
| gptkbp:wasFirstSynthesizedInYear |
1936
|
| gptkbp:bfsParent |
gptkb:5-MeO-DMT
|
| gptkbp:bfsLayer |
8
|